Neuroendocrine Carcinoma

Top drugs studied for this disease

CLINICAL_TRIALS withdrawal · 2013-07-10
Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy [Phase 2]
A Phase 2 clinical trial of antineoplaston therapy for Merkel cell carcinoma, islet cell carcinoma, neuroendocrine carcinoma, and pituitary …